<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02054143</url>
  </required_header>
  <id_info>
    <org_study_id>17637-1/2012/EKU</org_study_id>
    <secondary_id>DEOEC RKEB/IKEB:3584-2012</secondary_id>
    <nct_id>NCT02054143</nct_id>
  </id_info>
  <brief_title>The Effect of Sevoflurane on Cerebral CO2 Sensitivity and Systemic Arteries</brief_title>
  <official_title>The Effect of Sevoflurane on Cerebral Vasoreactivity Ans Systemic Arteries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Debrecen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Debrecen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose:&#xD;
&#xD;
        -  The purpose of this study is to examine the effect of different carbon-dioxide&#xD;
           concentrations on cerebral CO2 sensitivity and the resistance and stiffness of systemic&#xD;
           arteries during anesthesia with sevoflurane. Sevoflurane is a widely and commonly used&#xD;
           inhalational anaesthetic, that is mainly used for the maintenance of general anesthesia.&#xD;
&#xD;
        -  Changes in the velocity of cerebral blood flow and arterial stiffness due to the&#xD;
           different exhaled carbon-dioxide concentrations will allow us to conclude how&#xD;
           sevoflurane affects these parameters during the course of the narcosis.&#xD;
&#xD;
      Instruments:&#xD;
&#xD;
        -  An ultrasound device called transcranial doppler (TCD) is used to measure the velocity&#xD;
           of blood flow within a main artery located inside the skull.&#xD;
&#xD;
        -  A tonometry device named SphygmoCor is used to assess the pressure wave proceeding in&#xD;
           the radial artery, from which the stiffness of the systemic vessels can be concluded.&#xD;
&#xD;
      Measurements:&#xD;
&#xD;
      - Examinations with the ultrasound and tonometry devices are carried out once before the&#xD;
      operation, three times during the intervention, with different exhaled CO2 values and once&#xD;
      after the operation is completed.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      - Sevoflurane alters cerebral carbon-dioxide sensitivity and the stiffness of systemic&#xD;
      arteries.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study protocol:&#xD;
&#xD;
      - The study is conducted in four stages: in the first stage, measurements are performed&#xD;
      preoperatively in awake patients. Patients are placed in supine position and mean arterial&#xD;
      blood pressure (MAP), heart rate, oxygen saturation are measured. The transcranial doppler&#xD;
      (TCD) probe is fixed in place by applying a headband to maintain a constant angle of&#xD;
      insonation. Mean blood flow velocity (MBFV) and pulsatility index (PI) in the middle cerebral&#xD;
      artery (MCA) are obtained. MCA is insonated through the right temporal window by using pulsed&#xD;
      2 megahertz TCD ultrasound probe. Identification of the MCA is confirmed by using standard&#xD;
      criteria, at a depth of 45-55 mm. Cerebral CO2 vasoreactivity is calculated as the percentage&#xD;
      change in MBFV or PI for mmHg change in end-tidal CO2 (ETCO2).&#xD;
&#xD;
      SphygmoCor is placed on the left radial artery to obtain data about the central aortic blood&#xD;
      pressure, augmentation pressure (AP) and augmentation index normalised to a 75 beat per&#xD;
      minute heart rate (Alx75). From the derived aortic pulse, calculations can be made, using the&#xD;
      area under the systolic and diastolic part of the curve, to determine the heart's ratio of&#xD;
      oxygen supply and demand, it is called the subendocardial viability ratio (SEVR).&#xD;
&#xD;
      As part of the premedication each patient receives 7.5 mg midazolam. Anaesthesia is induced&#xD;
      using 2 mcg/kg fentanyl followed by 2 mg/kg propofol. Afterwards 0.6mg/kg rocuronium is given&#xD;
      for muscle paralysis and subsequently patients were intubated with a suitable intratracheal&#xD;
      tube.&#xD;
&#xD;
      After induction of anaesthesia, the patients are placed on a mechanical ventilation system,&#xD;
      using a volume-controlled setting with an air and oxygen mixture set to 0.4 fraction of&#xD;
      inspired oxygen (FiO2) , the fresh gas flow rate to 2 l/min and sevoflurane is adjusted to&#xD;
      reach a constant 1minimal alveolar concentration (MAC) during examination. Anesthesia is&#xD;
      maintained with sevoflurane and on demand fentanyl boluses.&#xD;
&#xD;
      Differences in the depth of anesthesia could influence cerebral activity, thereby cerebral&#xD;
      metabolism and blood flow. Bispectral index is placed onto every patient in order to assure&#xD;
      constant depth of anaesthesia during the intervention.&#xD;
&#xD;
      The second series of TCD and SphygmoCor measurements are performed 20 minutes after the&#xD;
      respiratory rate is set to maintain end-tidal CO2 at 40 mmHg in order to allow sufficient&#xD;
      time for equilibrium to be reached and the effect of drugs used for the induction of&#xD;
      anesthesia to be terminated. Subsequently the examinations are repeated twice again at 35 and&#xD;
      30 mmHg ETCO2. The measurements were carried out 5-5 minutes after adjusting the minute&#xD;
      ventilation to reach target ETCO2 values.&#xD;
&#xD;
      Statistical methods:&#xD;
&#xD;
      - Comparisons between the preoperative and three intraoperative stages of the study are made&#xD;
      using repeated measures ANOVA with the Bonferroni post hoc correction. The relationship&#xD;
      between MBFV, PI and ETCO2 is assessed using linear regression, while the connection between&#xD;
      SEVR, pulse and Alx75 is calculated with bivariate correlation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood flow velocity in the middle cerebral artery</measure>
    <time_frame>Changes from baseline in blood flow velocity at the 15th, 20th and 25th minutes of the operation</time_frame>
    <description>Systolic, diastolic and mean blood flow velocities are measured with transcranial doppler device.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial wall stiffness of the radial artery</measure>
    <time_frame>Changes from baseline in arterial stiffness at the 15th, 20th and 25th minutes of the operation</time_frame>
    <description>The stiffness of the radial artery is assessed. Stiffness rate is concluded from the augmentation pressure and augmentation index, from which both values are provided by the tonometry device.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the central systolic and diastolic blood pressure</measure>
    <time_frame>Changes from baseline in central blood pressure at the 15th, 20th and 25th minutes of the operation</time_frame>
    <description>CEntral blood pressure values are measured by means of tonometry device on the radial artery.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes in subendocardial viability ratio (SEVR)</measure>
    <time_frame>Changes form baseline in SEVR at the 15th, 20th and 25th minutes of the operation</time_frame>
    <description>From the derived central aortic pulse pressure, calculations can be made, using the area under the systolic and diastolic part of the curve.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Sevoflurane Anesthesia</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sevoflurane was administered to all patients at 1 minimal alveolar concentration (MAC) after the intubation occured until the patient was extubated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Partial pressure of CO2 at the end of an exhaled breath</intervention_name>
    <description>Three previously defined EtCO2 levels (partial pressure of CO2 at the end of an exhaled breath) were adjusted during anesthesia.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
    <other_name>EtCO2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Sevoflurane was administered to all patients at 1 minimal alveolar concentration (MAC) during the whole operation.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
    <other_name>Sevorane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Above the age 18&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) physical classification I. or II.&#xD;
&#xD;
          -  Patients undergoing elective varicotomy or inguinal hernioplasty in general anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with cerebral, cardiac or systemic vascular disorders (hypertension,&#xD;
             diabetes)&#xD;
&#xD;
          -  Patients receiving medication that affects the blood vessels (antihypertensive,&#xD;
             antidiabetic, antiarrhythmic medications)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Csilla Moln√°r, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Debrecen Medical and Health Science Center Department of Anesthesiology and Intensive Care 4032-Debrecen, Nagyerdei krt 98. Hungary Tel/fax: +36-52-255-347</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Debrecen Medical and Health Science Center Department of Anesthesiology and Intensive Care</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <study_first_submitted>January 31, 2014</study_first_submitted>
  <study_first_submitted_qc>February 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2014</study_first_posted>
  <last_update_submitted>February 3, 2014</last_update_submitted>
  <last_update_submitted_qc>February 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Debrecen</investigator_affiliation>
    <investigator_full_name>Tamas Vegh, MD</investigator_full_name>
    <investigator_title>assistant lecturer anesthesiologist and intensive care specialist</investigator_title>
  </responsible_party>
  <keyword>sevoflurane</keyword>
  <keyword>cerebral vasoreactivity</keyword>
  <keyword>arterial stiffness</keyword>
  <keyword>Transcranial Doppler</keyword>
  <keyword>SphygmoCor</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

